EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Predeposit Autologous Blood Donation in Rh(D)-Negative Pregnant Women: A Single-Center Study

Juan Xie iD, Yu Ling iD, Xiaoyu Zhou iD

American Journal of Perinatology Reports · 01.07.2024 · 14 (03) · e208-e214

DOI: 10.1055/a-2388-3298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology Reports, erschienen am 01.07.2024. Verfasst von Juan Xie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Special Funds for Health Science and Technology Development of Nanjing City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The primary purpose of this study was to assess the practicability of predeposit autologous blood donation (PABD) in the practice of Rh(D)-negative pregnant women. Materials and Methods A cohort of 405 Rh(D)-negative pregnant women who had a delivery in the comprehensive tertiary hospital in Nanjing was analyzed retrospectively, over 10 years.

Results

After PABD, 203 women experienced a slight drop in mean hemoglobin of 5.32 ± 0.5 g/L (PABD-associated anemia was not featured in our study). Thirteen women who received allogeneic blood might benefit from PABD practically.

Conclusion

PABD is applicable for Rh(D)-negative pregnant women, as it ensures the availability of the patient's blood in the event of perinatal hemorrhage, thus minimizing the need for transfusion from external sources. Despite the autologous blood reinfusion of low proportion, PABD could still serve as an alternative when allogeneic blood resources are scarce. However, one challenge in the future is to identify candidates who may benefit most from PABD. Also, more attention is needed to raise awareness of patient blood management. Recommended strategies include early screening and treatment of anemia, hemostasis promotion, and blood loss reduction. Replacement of allogeneic transfusion with autotransfusion could be referred to where feasible. We believe that PABD still has a promising potential for application in Rh(D)-negative pregnant women.

Schlagwörter

Stichwörter der Autor:innen

gestational anemiapatient blood managementpostpartum hemorrhagepredeposit autologous blood donation

Autor:innen und Institutionen

  • Department of Blood Transfusion, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
  • Department of Blood Transfusion, Nanjing Women and Children's Healthcare Hospital, Women's Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.

ORCID-Profile: Juan Xie, Yu Ling, Xiaoyu Zhou

Förderung

  • Special Funds for Health Science and Technology Development of Nanjing City

Zitieren

APA

Xie, J., Ling, Y., & Zhou, X. (2024). Predeposit Autologous Blood Donation in Rh(D)-Negative Pregnant Women: A Single-Center Study. American Journal of Perinatology Reports, 14(03), e208-e214. https://doi.org/10.1055/a-2388-3298

Vancouver

Xie J, Ling Y, Zhou X. Predeposit Autologous Blood Donation in Rh(D)-Negative Pregnant Women: A Single-Center Study. American Journal of Perinatology Reports. 2024;14(03):e208-e214. doi:10.1055/a-2388-3298

BibTeX
@article{Xie2024,
  author = {Xie, Juan and Ling, Yu and Zhou, Xiaoyu},
  title = {Predeposit Autologous Blood Donation in Rh(D)-Negative Pregnant Women: A Single-Center Study},
  journal = {American Journal of Perinatology Reports},
  year = {2024},
  volume = {14},
  number = {03},
  pages = {e208--e214},
  doi = {10.1055/a-2388-3298}
}
Kostenlos starten →